ID

34153

Beschrijving

MIBG Scintigraphy and Strain Echocardiography in the Detection of Subclinical Cardiovascular Effects One Year After (Neo)Adjuvant Breast Cancer Treatment With Docetaxel, Doxorubicin and Cyclophosphamide (TAC): a Pilot Study; ODM derived from: https://clinicaltrials.gov/show/NCT01246856

Link

https://clinicaltrials.gov/show/NCT01246856

Trefwoorden

  1. 14-01-19 14-01-19 -
Houder van rechten

see on clinicaltrials.gov

Geüploaded op

14 januari 2019

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY 4.0

Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Eligibility Breast Cancer NCT01246856

Eligibility Breast Cancer NCT01246856

Inclusion Criteria
Beschrijving

Inclusion Criteria

Alias
UMLS CUI
C1512693
female patients with breast cancer, ≥ 18 years old at the time of breast cancer diagnosis
Beschrijving

ID.1

Datatype

boolean

(neo)adjuvant treatment with docetaxel, doxorubicin and cyclophosphamide (tac) completed one year before inclusion
Beschrijving

ID.2

Datatype

boolean

Exclusion Criteria
Beschrijving

Exclusion Criteria

Alias
UMLS CUI
C0680251
evidence of breast cancer recurrence or metastatic disease
Beschrijving

ID.3

Datatype

boolean

evidence of heart disease at the time of breast cancer diagnosis
Beschrijving

ID.4

Datatype

boolean

evidence of renal failure at the time of cardiac evaluation
Beschrijving

ID.5

Datatype

boolean

pregnant or lactating
Beschrijving

ID.6

Datatype

boolean

participation in a research protocol with ionizing radiation within one year before inclusion.
Beschrijving

ID.7

Datatype

boolean

evidence of diabetes mellitus or parkinson's disease
Beschrijving

ID.8

Datatype

boolean

evidence of an mibg-accumulating tumor (pheochromocytoma, paraganglioma, chemodectoma, ganglioneuroma, neuroblastoma, carcinoid, medullary thyroid cancer, neurofibromatosis, retinoblastoma, esthesioneuroma, schwannoma, merkelcel-tumor, pancreatic islet cell tumors, small cell lung carcinoma, melanoma
Beschrijving

ID.9

Datatype

boolean

Similar models

Eligibility Breast Cancer NCT01246856

Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
female patients with breast cancer, ≥ 18 years old at the time of breast cancer diagnosis
boolean
ID.2
Item
(neo)adjuvant treatment with docetaxel, doxorubicin and cyclophosphamide (tac) completed one year before inclusion
boolean
Item Group
C0680251 (UMLS CUI)
ID.3
Item
evidence of breast cancer recurrence or metastatic disease
boolean
ID.4
Item
evidence of heart disease at the time of breast cancer diagnosis
boolean
ID.5
Item
evidence of renal failure at the time of cardiac evaluation
boolean
ID.6
Item
pregnant or lactating
boolean
ID.7
Item
participation in a research protocol with ionizing radiation within one year before inclusion.
boolean
ID.8
Item
evidence of diabetes mellitus or parkinson's disease
boolean
ID.9
Item
evidence of an mibg-accumulating tumor (pheochromocytoma, paraganglioma, chemodectoma, ganglioneuroma, neuroblastoma, carcinoid, medullary thyroid cancer, neurofibromatosis, retinoblastoma, esthesioneuroma, schwannoma, merkelcel-tumor, pancreatic islet cell tumors, small cell lung carcinoma, melanoma
boolean

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial